REAl-world Outcomes in CHronic Lymphocytic Leukemia Patients Receiving Acalabrutinib in Romania
Conditions: Chronic Lymphocytic Leukemia Interventions: Drug: Non interventional study Sponsors: AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: AstraZeneca | Chronic Leukemia | Chronic Lymphocytic Leukemia | Leukemia | Research | Romania Health | Study